Cushing Syndrome
48
17
19
10
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
8.3%
4 terminated out of 48 trials
71.4%
-15.1% vs benchmark
8%
4 trials in Phase 3/4
50%
5 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (48)
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
Institutional Registry of Rare Diseases
Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
Collecting Information About Treatment Results for Patients With Cushing's Syndrome
Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)
Adrenal Tumors - Pathogenesis and Therapy
A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
Open-label Treatment in Cushing's Syndrome
Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders
Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Quality of Life, Fatigue and Cognitive, Affective and Emotional Dysfunction in Patients With Cushing's Syndrome
Cushing's Syndrome Before and After Treatment (CORRECT)
Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome
NAC- NAFLD and Cushing
Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models
Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data